LncRNA HAGLROS contribute to papillary thyroid cancer progression by modulating miR-206/HMGA2 expression
Aging · 2023
DOI: 10.18632/aging.205321 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging, 2023. Verfasst von Zhaohui Zeng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Hunan Provincial People’s Hospital (The First Affiliated Hospital of Hunan Normal University), Changsha 410001, Hunan…. Hauptthemen laut MEDLINE: MicroRNAs, RNA, Long Noncoding, Thyroid Cancer, Papillary, Thyroid Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Hunan Provincial People’s Hospital (The First Affiliated Hospital of Hunan Normal University), Changsha 410001, Hunan, China.
- Chenzhou First People’s Hospital, Beihu, Chenzhou 423000, Hunan, China.
Zitieren
APA
Zeng, Z., Tang, S., Chen, L., Hou, H., Liu, Y., & Li, J. (2023). LncRNA HAGLROS contribute to papillary thyroid cancer progression by modulating miR-206/HMGA2 expression. Aging. https://doi.org/10.18632/aging.205321
Vancouver
Zeng Z, Tang S, Chen L, Hou H, Liu Y, Li J. LncRNA HAGLROS contribute to papillary thyroid cancer progression by modulating miR-206/HMGA2 expression. Aging. 2023. doi:10.18632/aging.205321
BibTeX
@article{Zeng2023,
author = {Zeng, Zhaohui and Tang, Shengtao and Chen, Liping and Hou, Haiwen and Liu, Yuan and Li, Juhui},
title = {LncRNA HAGLROS contribute to papillary thyroid cancer progression by modulating miR-206/HMGA2 expression},
journal = {Aging},
year = {2023},
doi = {10.18632/aging.205321}
}
EUVIMED